Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$217K Sell
4,771
-32,724
-87% -$1.46M 0.01% 890
2020
Q1
$1.65M Sell
37,495
-16,663
-31% -$651K 0.07% 280
2019
Q4
$1.94M Buy
54,158
+4,290
+9% +$159K 0.06% 323
2019
Q3
$1.74M Buy
49,868
+33,102
+197% +$1.27M 0.06% 340
2019
Q2
$721K Buy
16,766
+2,189
+15% +$90.7K 0.03% 587
2019
Q1
$629K Buy
14,577
+2,939
+25% +$118K 0.02% 618
2018
Q4
$425K Sell
11,638
-19
-0.2% -$706 0.02% 644
2018
Q3
$468K Sell
11,657
-1,056
-8% -$42.2K 0.02% 744
2018
Q2
$487K Sell
12,713
-118
-0.9% -$4.34K 0.02% 723
2018
Q1
$440K Buy
+12,831
New +$451K 0.02% 746

Other funds holding QGEN

Brinker Capital's QGEN Position: Q2 2020 in Review

Brinker Capital reduced its Qiagen (QGEN) stake by 87% in Q2 2020, selling an estimated $1.46M and leaving 4,771 shares worth $217K. The position accounts for 0.01% of the portfolio, ranked #890.

Brinker Capital first reported a position in QGEN in Q1 2018 and has held it in 10 quarters since. The position peaked at $1.94M in Q4 2019. 276 funds tracked by Wall St. Rank hold QGEN as of Q2 2020.

  • Brinker Capital held 4,771 shares of Qiagen worth $217K as of Q2 2020.
  • Brinker Capital sold 32,724 Qiagen shares in Q2 2020, an estimated $1.46M.
  • Qiagen made up 0.01% of Brinker Capital's portfolio in Q2 2020, its #890 holding.
  • Brinker Capital first reported a position in Qiagen in Q1 2018 and has held it in 10 quarters since.
  • Brinker Capital's Qiagen position peaked at $1.94M in Q4 2019.
  • 276 funds tracked by Wall St. Rank held Qiagen as of Q2 2020.

Based on Brinker Capital's 13F filing for Q2 2020, filed 30 Jul 2020.